Cytochrome P450 1A2 co-determines neuroleptic load and may diminish tardive dyskinesia by increased inducibility; The World Journal of Biological Psychiatry; Vol. 16, iss. 3
| Parent link: | The World Journal of Biological Psychiatry Vol. 16, iss. 3.— 2015.— [P. 200-205] |
|---|---|
| Ente Autore: | Национальный исследовательский Томский политехнический университет (ТПУ) Институт неразрушающего контроля (ИНК) Кафедра экологии и безопасности жизнедеятельности (ЭБЖ) |
| Altri autori: | Ivanova S. A. Svetlana Aleksandrovna, Toshchakova V. A. Valentina Aleksandrovna, Filipenko M. L. Maksim Leonidovich, Fedorenko O. Yu. Olga Yurievna, Boyarko E. G. Evgeniya Grigorjevna, Semke A. V. Arkady Valentinovich, Bokhan N. A. Nikolay Aleksandrovich, Aftanas L. V. Lyubomir Ivanovich, Lunen A. D. Anton DzhM |
| Riassunto: | Title screen Objectives. The aim of this study was to investigate a possible association between tardive dyskinesia (TD) and CYP1A2 (*1F, -163C>А, rs762551) polymorphism in Russian psychiatric inpatients. Methods. TD was assessed cross-sectionally using the Abnormal Involuntary Movement Scale (AIMS). Orofacial and limb-truncal dyskinesia were assessed with AIMS 1–4 and 5–7, respectively. Standard protocols were applied for genotyping. Analysis of covariance (ANCOVA) was used to compare the mean AIMS scores for each of the genotypic classes. Results. A total of 319 Caucasian patients from West Siberia with schizophrenia and 117 healthy volunteers were investigated. No significant differences between the patients and the controls in genotype frequencies were found. Analysis of covariance (ANCOVA) with age, sex, duration of disease, chlorpromazine equivalent (CPZEQ) incorporated as covariates showed that limb-truncal, but not orofacial TD, is associated with CYP1A2 (?163C>, rs762551) polymorphism (F = 3.27, P = 0.039). Patients with the C/C genotype had a higher mean AIMS 5–7 score than those with the A/C or the A/A genotype. Conclusions. Our results support the hypothesis that not only with clozapine, but also with other classical and atypical antipsychotics, smoking may decrease plasma levels; this is most extensively expressed in carriers of the CYP1A2*1F (-163C> A) polymorphism. Режим доступа: по договору с организацией-держателем ресурса |
| Lingua: | inglese |
| Pubblicazione: |
2015
|
| Soggetti: | |
| Accesso online: | http://dx.doi.org/10.3109/15622975.2014.995222 |
| Natura: | MixedMaterials Elettronico Capitolo di libro |
| KOHA link: | https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=640158 |
Documenti analoghi
Pharmacogenetics of tardive dyskinesia in schizophrenia: The role of CHRM1 and CHRM2 muscarinic receptors; The World Journal of Biological Psychiatry; Latest Articles
Pubblicazione: (2018)
Pubblicazione: (2018)
A genome-wide association study identifies a gene network associated with paranoid schizophrenia and antipsychotics-induced tardive dyskinesia; Progress in Neuro-Psychopharmacology and Biological Psychiatry; Vol. 105
Pubblicazione: (2021)
Pubblicazione: (2021)
Cytochrome P450 Protocols
Pubblicazione: (2013)
Pubblicazione: (2013)
Cytochrome P450 Protocols
Pubblicazione: (1998)
Pubblicazione: (1998)
Cytochrome P450 Protocols
Pubblicazione: (2006)
Pubblicazione: (2006)
Cytochrome P450 In Vitro Methods and Protocols /
Pubblicazione: (2021)
Pubblicazione: (2021)
5-Hydroxytryptamine Receptors and Tardive Dyskinesia in Schizophrenia; Frontiers in Molecular Neuroscience; Vol. 13
Pubblicazione: (2020)
Pubblicazione: (2020)
Putative role of pharmacogenetics to elucidate the mechanism of tardive dyskinesia in schizophrenia; Pharmacogenomics; Vol. 20, iss. 17
di: Loonen A. J. M. Anton
Pubblicazione: (2019)
di: Loonen A. J. M. Anton
Pubblicazione: (2019)
No evidence so far of a major role of AKT1 and GSK3B in the pathogenesis of antipsychotic‐induced tardive dyskinesia; Human Psychopharmacology: Clinical and Experimental; Vol. 34, iss. 1
Pubblicazione: (2019)
Pubblicazione: (2019)
Application of the frontal polygon method in analysis of the structure - activity relation for urea derivatives: inducers of cytochrome p-450 in the liver; Pharmaceutical Chemistry Journal; Vol. 29, iss. 7
Pubblicazione: (1995)
Pubblicazione: (1995)
New Cytochrome P-450 Ligands Based on Urea Derivatives; Pharmaceutical Chemistry Journal; Vol. 39, iss. 1
Pubblicazione: (2005)
Pubblicazione: (2005)
NMDA glutamate receptor polymorphisms modulate antipsychotic-induced hyperprolactinemia in schizophrenia; Progress in Neuro-Psychopharmacology and Biological Psychiatry; Vol. 143
Pubblicazione: (2025)
Pubblicazione: (2025)
CYP1A2 and CYP2D6 Gene Polymorphisms in Schizophrenic Patients with Neuroleptic Drug-Induced Side Effects; Bulletin of Experimental Biology and Medicine; Vol. 160, iss. 5
Pubblicazione: (2016)
Pubblicazione: (2016)
Synthetic anticonvulsants, antioxidants, and inducers of the liver monooxygenase system based on amides and ureas; X; Inducers of the cytochrome-P-450-dependent monoxygenase system of the liver on the basis of dibenzazepinones, mono- and bicyclic imidazolamines and isoindolinones; Pharmaceutical Chemistry Journal; Vol. 27, iss. 9
Pubblicazione: (1993)
Pubblicazione: (1993)
Amide- and urea-based synthetic anticonvulsants, antihypoxics, and inducers of the hepatic monooxygenase system; IX; Synthesis and search for inducers of the liver cytochrome P-450-dependent monooxygenase system among carbamide-containing heterocyclic compounds; Pharmaceutical Chemistry Journal; Vol. 27, iss. 6
Pubblicazione: (1993)
Pubblicazione: (1993)
Amide- and urea-based synthetic anticonvulsants, antihypoxics, and inducers of the hepatic monooxygenase system; VII; Effect of benzhydrylureas on the cytochrome P-450-dependent liver monooxygenase system; Pharmaceutical Chemistry Journal; Vol. 27, iss. 6
Pubblicazione: (1993)
Pubblicazione: (1993)
Association Study Indicates a Protective Role of Phosphatidylinositol-4-Phosphate-5-Kinase against Tardive Dyskinesia; International Journal of Neuropsychopharmacology (IJNP); Vol. 18, iss. 6
Pubblicazione: (2015)
Pubblicazione: (2015)
Likelihood of mechanistic roles for dopaminergic, serotonergic and glutamatergic receptors in tardive dyskinesia: A comparison of genetic variants in two independent patient populations; SAGE Open Medicine; Vol. 4
Pubblicazione: (2016)
Pubblicazione: (2016)
Tasman’s Psychiatry
Pubblicazione: (2023)
Pubblicazione: (2023)
Textbook of Community Psychiatry American Association for Community Psychiatry /
Pubblicazione: (2022)
Pubblicazione: (2022)
Ethics in Psychiatry European Contributions /
Pubblicazione: (2025)
Pubblicazione: (2025)
Polymorphisms of Catechol-O-Methyl Transferase (COMT) Gene in Vulnerability to Levodopa-Induced Dyskinesia; Journal of Pharmacy and Pharmaceutical Sciences (JPPS); Vol. 21
Pubblicazione: (2018)
Pubblicazione: (2018)
Psychiatry and Decolonisation in Uganda
di: Pringle, Yolana
Pubblicazione: (2019)
di: Pringle, Yolana
Pubblicazione: (2019)
Psychiatry Interrogated An Institutional Ethnography Anthology /
Pubblicazione: (2016)
Pubblicazione: (2016)
Levodopa-Induced Dyskinesia Is Related to Indirect Pathway Medium Spiny Neuron Excitotoxicity: A Hypothesis Based on an Unexpected Finding; Parkinson’s Disease; Vol. 2016
di: Ivanova S. A. Svetlana Aleksandrovna
Pubblicazione: (2016)
di: Ivanova S. A. Svetlana Aleksandrovna
Pubblicazione: (2016)
№ 5 (450); Судостроение
Pubblicazione: (1975)
Pubblicazione: (1975)
Child and Adolescent Psychiatry Asian Perspectives /
Pubblicazione: (2016)
Pubblicazione: (2016)
Continental Philosophy of Psychiatry The Lure of Madness /
di: Morgan, Alastair
Pubblicazione: (2022)
di: Morgan, Alastair
Pubblicazione: (2022)
Decolonization of Psychiatry in Jamaica Madnificent Irations /
di: Hickling, Frederick W.
Pubblicazione: (2021)
di: Hickling, Frederick W.
Pubblicazione: (2021)
Quantitative structure - Activity relationships in a series of urea derivatives - Liver cytochrome P-450 inductors analyzed by the modified method of frontal polyhedral; Pharmaceutical Chemistry Journal; Vol. 31, iss. 6
Pubblicazione: (1997)
Pubblicazione: (1997)
Buddhism and Psychiatry Moving Beyond Mindfulness in Mental Health Care /
di: Kelly, Brendan
Pubblicazione: (2025)
di: Kelly, Brendan
Pubblicazione: (2025)
Animal Models in Psychiatry, I
Pubblicazione: (1991)
Pubblicazione: (1991)
Handbook of Recovery in Inpatient Psychiatry
Pubblicazione: (2016)
Pubblicazione: (2016)
Systemische Praxis in der Psychiatrie
Pubblicazione: (Bonn, Psychiatrie-Verlag, 1996)
Pubblicazione: (Bonn, Psychiatrie-Verlag, 1996)
Animal Models in Psychiatry, II
Pubblicazione: (1992)
Pubblicazione: (1992)
Documentary Film and Radical Psychiatry
di: O'Rawe, Des
Pubblicazione: (2024)
di: O'Rawe, Des
Pubblicazione: (2024)
Social Psychiatry in South Asia
Pubblicazione: (2025)
Pubblicazione: (2025)
The Revolt Against Psychiatry A Counterhegemonic Dialogue /
di: Burstow, Bonnie
Pubblicazione: (2019)
di: Burstow, Bonnie
Pubblicazione: (2019)
Biological profile of medical response in alcoholic patients of different ethnic groups in Siberia; European Psychiatry; Vol. 64, Special iss. S1 : Abstracts of the 29th European Congress of Psychiatry, April 2021
Pubblicazione: (2021)
Pubblicazione: (2021)
An association of AKT1 gene polymorphism with antidepressant treatment response; The World Journal of Biological Psychiatry; Vol. 17, iss. 3
Pubblicazione: (2016)
Pubblicazione: (2016)
Documenti analoghi
-
Pharmacogenetics of tardive dyskinesia in schizophrenia: The role of CHRM1 and CHRM2 muscarinic receptors; The World Journal of Biological Psychiatry; Latest Articles
Pubblicazione: (2018) -
A genome-wide association study identifies a gene network associated with paranoid schizophrenia and antipsychotics-induced tardive dyskinesia; Progress in Neuro-Psychopharmacology and Biological Psychiatry; Vol. 105
Pubblicazione: (2021) -
Cytochrome P450 Protocols
Pubblicazione: (2013) -
Cytochrome P450 Protocols
Pubblicazione: (1998) -
Cytochrome P450 Protocols
Pubblicazione: (2006)